{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:27:15Z","timestamp":1782199635054,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.dsx.2023.102847","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T20:00:15Z","timestamp":1692820815000},"page":"102847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Automated glycemic control with a bionic pancreas for type 1 diabetes mellitus: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9704-3471","authenticated-orcid":false,"given":"Puguh","family":"Oktavian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Setyo","family":"Budi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idznika Nurannisa","family":"Wibowo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyna Cesariyani Rahmadianti","family":"Rusuldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avianita Dewi","family":"Kusumawardhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifan Ali","family":"Wafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamzah Rafly","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nando Reza","family":"Pratama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2339-5266","authenticated-orcid":false,"given":"Sony Wibisono","family":"Mudjanarko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2023.102847_bib1","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Diabetes control and complications trial\/epidemiology of diabetes interventions and complications (DCCT\/EDIC) study research group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dsx.2023.102847_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diaclin.26.2.77","article-title":"Microvascular and macrovascular complications of diabetes","volume":"26","author":"Fowler","year":"2008","journal-title":"Clin Diabetes"},{"key":"10.1016\/j.dsx.2023.102847_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/dia.2018.0384","article-title":"State of type 1 diabetes management and outcomes from the T1D exchange in 2016\u20132018","volume":"21","author":"Foster","year":"2019","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.dsx.2023.102847_bib4","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.2337\/dc19-0830","article-title":"Incidences of severe hypoglycemia and diabetic ketoacidosis and prevalence of microvascular complications stratified by age and glycemic control in U.S. Adult patients with type 1 diabetes: a real-world study","volume":"42","author":"Pettus","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2023.102847_bib5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","article-title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","volume":"10","author":"Gregory","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.dsx.2023.102847_bib6","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMoa2205225","article-title":"Multicenter, randomized trial of a bionic pancreas in type 1 diabetes","volume":"387","author":"Russell","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dsx.2023.102847_bib7","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1089\/dia.2022.0341","article-title":"The insulin-only bionic pancreas pivotal trial extension study: a multi-center single-arm evaluation of the insulin-only configuration of the bionic pancreas in adults and youth with type 1 diabetes","volume":"24","author":"Lynch","year":"2022","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.dsx.2023.102847_bib8","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1089\/dia.2022.0167","article-title":"A multicenter randomized trial evaluating fast-acting insulin aspart in the bionic pancreas in adults with type 1 diabetes","volume":"24","author":"Beck","year":"2022","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.dsx.2023.102847_bib9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1089\/dia.2022.0200","article-title":"A multicenter randomized trial evaluating the insulin-only configuration of the bionic pancreas in adults with type 1 diabetes","volume":"24","author":"Kruger","year":"2022","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.dsx.2023.102847_bib10","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1089\/dia.2022.0201.pub","article-title":"Positive impact of the bionic pancreas on diabetes control in youth 6\u201317 Years old with type 1 diabetes: a multicenter randomized trial","volume":"24","author":"Messer","year":"2022","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.dsx.2023.102847_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(16)32567-3","article-title":"Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial","volume":"389","author":"El-Khatib","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.dsx.2023.102847_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S2213-8587(15)00489-1","article-title":"Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial","volume":"4","author":"Russell","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.dsx.2023.102847_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1056\/NEJMoa1314474","article-title":"Outpatient glycemic control with a bionic pancreas in type 1 diabetes","volume":"371","author":"Russell","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dsx.2023.102847_bib14","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.2337\/dc12-0071","article-title":"Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas","volume":"35","author":"Russell","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2023.102847_bib15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ecl.2010.05.011","article-title":"Epidemiology of type 1 diabetes","volume":"39","author":"Maahs","year":"2010","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.dsx.2023.102847_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1002853","article-title":"Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes","volume":"363","author":"Bergenstal","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dsx.2023.102847_bib17","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2337\/dc15-0078","article-title":"Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D exchange clinic registry","volume":"38","author":"Miller","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2023.102847_bib18","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1089\/dia.2005.7.876","article-title":"Insulin pump therapy in preschool children with type 1 diabetes mellitus improves glycemic control and decreases glucose excursions and the risk of hypoglycemia","volume":"7","author":"Jeha","year":"2005","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.dsx.2023.102847_bib19","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00125-002-0822-9","article-title":"Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes","volume":"45","author":"Cryer","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2023.102847_bib20","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2023.102847_bib21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s13340-017-0327-x","article-title":"Exploring the molecular mechanisms underlying \u03b1- and \u03b2-cell dysfunction in diabetes","volume":"8","author":"Kawamori","year":"2017","journal-title":"Diabetology International"},{"key":"10.1016\/j.dsx.2023.102847_bib22","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1371\/journal.pmed.0040069","article-title":"Defective awakening response to nocturnal hypoglycemia in patients with type 1 diabetes mellitus","volume":"4","author":"Schultes","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.dsx.2023.102847_bib23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/dme.13581","article-title":"Dual-hormone artificial pancreas: benefits and limitations compared with single-hormone systems","volume":"35","author":"Peters","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/j.dsx.2023.102847_bib24","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1177\/193229681000400603","article-title":"Factors influencing the effectiveness of glucagon for preventing hypoglycemia","volume":"4","author":"Castle","year":"2010","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.dsx.2023.102847_bib25","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.2337\/dc14-0803","article-title":"Quantification of the glycemic response to microdoses of subcutaneous glucagon at varying insulin levels","volume":"37","author":"El Youssef","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2023.102847_bib26","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1177\/193229681000400602","article-title":"Efficacy determinants of subcutaneous microdose glucagon during closed-loop control","volume":"4","author":"Russell","year":"2010","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.dsx.2023.102847_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000619","article-title":"A bihormonal closed-loop artificial pancreas for type 1 diabetes","volume":"2","author":"El-Khatib","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.dsx.2023.102847_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/dia.2020.0083","article-title":"Fast-acting insulin aspart use with the MiniMedTM 670G system","volume":"23","author":"Hsu","year":"2021","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.dsx.2023.102847_bib29","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.2337\/dc21-0814","article-title":"Fast-acting insulin aspart versus insulin aspart using a second-generation hybrid closed-loop system in adults with type 1 diabetes: a randomized, open-label, crossover trial","volume":"44","author":"Lee","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2023.102847_bib30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/dia.2016.0112","article-title":"Interstitial fluid glucose is not just a shifted-in-time but a distorted mirror of blood glucose: insight from an in silico study","volume":"18","author":"Cobelli","year":"2016","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.dsx.2023.102847_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1932296814525825","article-title":"What are the next steps in continuous glucose monitoring?","volume":"8","author":"Lodwig","year":"2014","journal-title":"J Diabetes Sci Technol"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402123001431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402123001431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:23:05Z","timestamp":1761729785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402123001431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1871402123001431"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2023.102847","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Automated glycemic control with a bionic pancreas for type 1 diabetes mellitus: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2023.102847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC). Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102847"}}